CareDx Inc (CDNA) Stock Analysis

Sector: HEALTHCARE - DIAGNOSTICS & RESEARCH

Exchange: NASDAQ

Key Metrics

• Price: $18.82
• Market Cap: $982.57M
• P/E Ratio: 14.42
• EPS: $1.28
• 52-Week High: $22.61
• 52-Week Low: $10.96

Market Sentiment

CareDx Inc currently has a Bullish sentiment score of 0.20.

About CareDx Inc

CareDx, Inc. is a pioneering biotechnology company headquartered in South San Francisco, California, dedicated to transforming transplant medicine through advanced diagnostic solutions. The company specializes in innovative surveillance tools that significantly enhance transplant outcomes and facilitate personalized care for organ transplant recipients. With a comprehensive portfolio of cutting-edge tests and software platforms, CareDx is committed to improving the quality of life for patient...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for CareDx Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does CDNA pay dividends?

CareDx Inc (CDNA) does not currently pay a regular dividend.

What is CDNA's P/E ratio?

CareDx Inc has a price-to-earnings (P/E) ratio of 14.42.

What is CDNA's market cap?

CareDx Inc (CDNA) has a market capitalization of $982.57M with a current stock price of $18.82.